Dergiler / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 3

Evaluation of Geriatric Patients Hospitalized for Toxic Hepatitis in a University Hospital

Sayfa
303–307
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Discussion and Conclusion: The geriatric population is at risk for toxic hepatitis due to age-related physiological changes, polypharmacy, higher rates of chronic disease, and more frequent use of herbal medicines.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: Toxic hepatitis is a common condition that causes impaired liver function.
📊
Temel Bulgular & Veri:In the geriatric population, factors that further increase the existing risk of toxic hepatitis include an age-related physiological decline in liver function, polypharmacy and the use of herbal products as natural remedies for health problems.
💡
Sonuç & Katkı:Discussion and Conclusion: The geriatric population is at risk for toxic hepatitis due to age-related physiological changes, polypharmacy, higher rates of chronic disease, and more frequent use of herbal medicines.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Introduction: Toxic hepatitis is a common condition that causes impaired liver function. In the geriatric population, factors that further increase the existing risk of toxic hepatitis include an age-related physiological decline in liver function, polypharmacy and the use of herbal products as natural remedies for health problems. This study aims to investigate the causes of toxic hepatitis and comorbid clinical conditions in patients aged 65 years and over who were hospitalized for toxic hepatitis. Methods: Data were collected by retrospective analysis of the medical records of 15 patients aged 65 years and older who were treated for toxic hepatitis in the geriatric ward of a university hospital between January 2019 and December 2019. Results: The mean age of the patients was 69.53±7.22, and 73.3% (n=11) were women. The most common chronic comorbidity was hypertension (46.7%). The most common suspected etiological factor for toxic hepatitis was an edible plant from the genus Ferula that is cultivated in the wild in Erzurum and its vicinity (locally known as çaşır otu). None of the patients developed fulminant hepatic failure or acute tubular necrosis during follow-up. All 15 patients in this study recovered and were discharged. Discussion and Conclusion: The geriatric population is at risk for toxic hepatitis due to age-related physiological changes, polypharmacy, higher rates of chronic disease, and more frequent use of herbal medicines.

🔖

Bu Makaleye Atıf Yap

TOSUN, P. T., KARAŞAHİN, Ö., VURAL, M. F., DELİBAS, D. H. (2020). Evaluation of Geriatric Patients Hospitalized for Toxic Hepatitis in a University Hospital. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 3, 303–307. https://ajindex.com/articles/199684

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (18)

  1. Arıcı S. Toksik hepatit. Pamukkale Tıp Dergisi 2008;1:113–9
  2. Broulac-Sage P, Balabaud C. Liver, Biliary tract and Pancreas. In: Odze JG, Crawford J, editors. Toxic and drug induced disorders of the liver in Surgical Pathology of the GI tract. Philadelphia: Saunders. 2004. p. 833–61
  3. Lucena MI, García-Cortés M, Cueto R, Lopez-Duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141–58
  4. Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf 2007;30:277–94
  5. Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 2007;6:673–84
  6. Kerry Z. Yaşlılarda Doğru İlaç Kullanımı. Ege Journal of Medicine. 2015;54:62-73
  7. Gelal A. Yaşlılarda akılcı ilaç kullanımı. Türkiye Klinikleri J Pharmacol-Special Topics 2015;3:57–64
  8. Karaman E, Taşar TP, Timur O, Kiper YP, Yıldırım Y. To Determined Using of Herbal Product in Elderly People. Turkiye Klinikleri J Med Sci. 2019;39:170–8
  9. Özdemir S. Liver diseases in the elderly. Cerrahpaşa Journal of Medicine 2001;32:120–7
  10. Woodhouse K, Wynne HA. Age-related changes in hepatic function. Implications for drug therapy. Drugs Aging 1992;2:243-55
  11. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989;9:297–301
  12. Kitani K. Aging of the liver: facts and theories. Arch Gerontol Geriatr 1991;12:133–54
  13. Triantafyllou K, Vlachogiannakos J, Ladas SD. Gastrointestinal and liver side effects of drugs in elderly patients. Best Pract Res Clin Gastroenterol 2010;24:203–15
  14. Le Couteur DG, Cogger VC, Markus AM, Harvey PJ, Yin ZL, Ansselin AD, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001;33:537–43
  15. Le Couteur DG, Fraser R, Cogger VC, McLean AJ. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 2002;359:1612–5
  16. Canter PH, Ernst E. Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions. Drugs Aging 2004;21:597–605
  17. Monti M, Pinotti M, Appendino G, Dallocchio F, Bellini T, Antognoni F, et al. Characterization of anti-coagulant properties of prenylated coumarin ferulenol. Biochim Biophys Acta 2007;1770:1437–40
  18. Kang SH, Kim JI, Jeong KH, Ko KH